Skip to main content
Caplight Logo









Theracle

Theracle

Private
Milpitas, CaliforniaHealthcare & Life Scienceshttps://www.theracle.com/

Last Round

VC Round

Oct 6, 2025

Company Overview

Theracle operates in Healthcare & Life Sciences and is based in Milpitas, California. Its latest recorded funding round was a VC Round in October 2025.

Theracle is a medical technology company developing an implantable drug-delivery platform designed to bypass the blood-brain barrier for the treatment of neurological conditions and brain cancers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Theracle Comparables

Compare Theracle with similar companies based on industry and business-model similarity.

Theracle comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cognos Therapeutics Inc
86%
CraniUS Therapeutics
85%
Carthera
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Theracle Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 6, 2025
AcceleratorMay 2, 2013
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Greg Method

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 6, 2025

    Raised a VC Round with participation from Neuroceuticals Inc.

  • May 2, 2013

    Accelerator round led by InCube Labs

Book a demo to see all signals

For institutional investors. Book with your work email.

Theracle Filings

Explore SEC and related filing metadata, where available.

Theracle filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Theracle's valuation, stock price, and market status.

Is Theracle a public or private company?

Theracle is a private company.

What is the current stock price of Theracle?

Theracle is a private company, so its shares have no public market price. Caplight tracks Theracle's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Theracle worth (valuation)?

Valuation information for Theracle is not publicly available.

Can I buy Theracle stock?

Theracle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Theracle's last funding round?

Theracle's most recent funding round was VC Round on October 6, 2025.

Who are the main investors in Theracle?

Investor information for Theracle is not publicly disclosed.

Will Theracle IPO soon?

No public IPO plans have been announced for Theracle.

How can I track Theracle secondary market activity?

Caplight tracks bids, offers, and trades in Theracle's shares on secondary markets.

Firmographic Details

HeadquartersMilpitas, California
Employee Range1
Year Founded2014
Last FundingOct 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?